Recombinant SARS-CoV-2 Spike antibody (RBD)

Catalog No. ABIN7233209

The Tobacco (Nicotiana benthamiana) Monoclonal anti-SARS-CoV-2 Spike antibody has been validated for ELISA and WB. It is suitable to detect SARS-CoV-2 Spike in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Spike antibody (RBD) (ABIN7233209)

Target: SARS-CoV-2 Spike

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Tobacco (Nicotiana benthamiana)

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Clone: CR3022

Product Details anti-SARS-CoV-2 Spike Antibody

Binding Specificity: RBD

Purpose: Human Anti-SARS-CoV-2 RBD (CR3022) Antibody

Specificity: CR3022 variable regions fused to human IgG1: Heavy chain CR3022 (GenBank: DQ168569.1) - Human Heavy chain IgG1 (UniProtKB/Swiss-Prot: P01857.1) Light chain CR3022 (GenBank: DQ168570.1) - Human kappa chain (UniProtKB/Swiss-Prot: P01834.2)

Characteristics: Monoclonal antibody to COVID-19 & SARS-CoV S glycoprotein. Recombinantly expressed in Nicotiana benthamiana plants.

Purification: This product was purified by Protein A affinity chromatography.

Purity: 90-95 %

Immunogen: SARS-CoV-2 RBD

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2 mg/mL

Buffer: Phosphate Buffered saline (PBS)  0.1M pH 7.4. Preservative: none

Preservative: Without preservative

Storage: 4 °C,-20 °C

Storage Comment: Short term: 2 - 4°C. Long term: -20°C

Target Details for SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike